• Kyodo


The government-backed Riken scientific research institute said Thursday it has applied for government permission to conduct clinical research using induced pluripotent stem cells, known as iPS cells, to regenerate retinas.

If the ministry accepts Riken’s plan, it would be the world’s first clinical research using iPS cells, which grow into different kinds of human body tissue.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.